At the news
? NEUTRALIMPACT 2/10 DEFA14A filed Apr 6, 2026 at 08:49 ET
Treace Medical Concepts, Inc. filed a definitive proxy statement (DEFA14A) for its 2026 annual meeting. The filing is routine and does not contain any new material financial information or significant corporate actions.
- The filing is a routine proxy statement (DEFA14A) for the 2026 annual meeting.
- No material financial data, new agreements, or significant corporate actions are disclosed in the filing.
- The filing type is standard and does not indicate any immediate changes in company operations or strategy.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access